Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Malecare is a U.S.-based 501(c)(3) nonprofit healthcare organization focused primarily on prostate cancer patient support, advocacy, education, and survivorship services. Founded in 1998, it operates large in-person and online prostate cancer support networks and has developed specialized programs for advanced disease, younger men, gay and bisexual men, and Black men affected by prostate cancer. In addition to peer support and patient education, the organization has built digital and innovation initiatives including the Cancer Academy e-learning platform, the Cancer Copilot AI chatbot, the CancerGraph symptom tracker, and the Start A Cure research crowdfunding platform. Malecare also participates in research and advocacy, including NIH/NCI-funded survivorship work and broader global prostate cancer alliance efforts. It is not a drug-development biotech or pharma company, but it is clearly a healthcare-focused organization active in oncology support and patient engagement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Malecare.